EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

por Xia, Lin, Zheng, Zao‐zao, Liu, Jun‐yi, Chen, Yu‐jie, Ding, Jian‐cheng, Xia, Ning‐shao, Luo, Wen‐xin, Liu, Wen
Publicado 2020

BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma

por Xia, Lin, Liu, Jun-yi, Zheng, Zao-zao, Chen, Yu-jie, Ding, Jian-cheng, Hu, Ya-hong, Hu, Guo-sheng, Xia, Ning-shao, Liu, Wen
Publicado 2021

Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer

por Zheng, Zao-zao, Xia, Lin, Hu, Guo-sheng, Liu, Jun-yi, Hu, Ya-hong, Chen, Yu-jie, Peng, Jia-yin, Zhang, Wen-juan, Liu, Wen
Publicado 2022

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

por Xia, Lin, Yuan, Lun-zhi, Hu, Ya-hong, Liu, Jun-yi, Hu, Guo-sheng, Qi, Ruo-yao, Zhang, Tian-ying, Xiong, Hua-long, Zheng, Zao-zao, Lin, Hong-wei, Zhang, Jia-mo, Yu, Chao, Zhou, Ming, Ma, Jian, Cheng, Tong, Chen, Ri-rong, Guan, Yi, Xia, Ning-shao, Liu, Wen
Publicado 2023